653 related articles for article (PubMed ID: 19356792)
21. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
22. [The results of specific immunotherapy for house dust mites in patients with allergic rhinitis].
Sahin E; Taş E; Dağtekin Ergür EN; Cuhali BD; Gürsel AO
Kulak Burun Bogaz Ihtis Derg; 2008; 18(2):79-84. PubMed ID: 18628641
[TBL] [Abstract][Full Text] [Related]
23. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
[TBL] [Abstract][Full Text] [Related]
24. [Monitoring the efficacy of immunotherapy by symptom scores and the skin prick test in patients with allergic rhinitis].
Akbaş Y; Saatçi MR
Kulak Burun Bogaz Ihtis Derg; 2003 Jun; 10(6):221-5. PubMed ID: 13679688
[TBL] [Abstract][Full Text] [Related]
25. Correlation of immunoglobulin E, eosinophil cationic protein, and eosinophil count with the severity of childhood perennial allergic rhinitis.
Chen ST; Sun HL; Lu KH; Lue KH; Chou MC
J Microbiol Immunol Infect; 2006 Jun; 39(3):212-8. PubMed ID: 16783451
[TBL] [Abstract][Full Text] [Related]
26. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus.
Piazza I; Bizzaro N
Ann Allergy; 1993 Nov; 71(5):461-9. PubMed ID: 7755664
[TBL] [Abstract][Full Text] [Related]
27. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.
Marcucci F; Sensi L; Di Cara G; Salvatori S; Bernini M; Pecora S; Burastero SE
Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400
[TBL] [Abstract][Full Text] [Related]
28. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
[TBL] [Abstract][Full Text] [Related]
29. [The effect of specific immunotherapy on the regulation of Th1/Th2 cell ratio of the patients with allergic rhinitis in serum].
Xiao C; Li H; Li H; Cheng Z; Qin J; Zhou W; He Q; Xu X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Oct; 24(20):924-7. PubMed ID: 21171297
[TBL] [Abstract][Full Text] [Related]
30. [Clinical efficacy and immunological changes in children with allergic rhinitis receiving specific immunotherapy with Dermatophagoides pteronyssinus].
Wang CS; Zhang W; Wang XD; Xi L; Ouyang YH; Zhao Y; Wang Y; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 46(1):36-9. PubMed ID: 21429334
[TBL] [Abstract][Full Text] [Related]
31. [Clinical efficacy of immunotherapy with house dust in the patients with perennial nasal allergy].
Takeuchi K; Kishioka C; Yuta A; Sakakura Y; Masuda S; Ukai K; Majima Y
Arerugi; 2000 Aug; 49(8):627-33. PubMed ID: 11021014
[TBL] [Abstract][Full Text] [Related]
32. Skin tests, T cell responses and self-reported symptoms in children with allergic rhinitis and asthma due to house dust mite allergy.
Moed H; van Wijk RG; de Jongste JC; van der Wouden JC
Clin Exp Allergy; 2009 Feb; 39(2):222-7. PubMed ID: 19032359
[TBL] [Abstract][Full Text] [Related]
33. [Evaluating total serum IgE levels and peripheral eosinophil count in asthma and rhinitis].
Takahashi A; Konno S; Isada A; Hattori T; Shimizu K; Shimizu K; Taniguchi N; Takahashi D; Taniguchi M; Akazawa A; Hizawa N; Nishimura M
Arerugi; 2010 May; 59(5):536-44. PubMed ID: 20502102
[TBL] [Abstract][Full Text] [Related]
34. Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis.
Brimnes J; Kildsgaard J; Jacobi H; Lund K
Clin Exp Allergy; 2007 Apr; 37(4):488-97. PubMed ID: 17430344
[TBL] [Abstract][Full Text] [Related]
35. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
36. [IgE values in nasal mucus in the diagnosis of perennial allergic rhinitis].
Olivé Pérez A; Cisteró Bahima A
Allergol Immunopathol (Madr); 1981; 9(2):131-6. PubMed ID: 7293876
[TBL] [Abstract][Full Text] [Related]
37. Recent progress in allergen immunotherapy.
Nouri-Aria KT
Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
[TBL] [Abstract][Full Text] [Related]
38. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
Asturias JA; Ibarrola I; Arilla MC; Vidal C; Ferrer A; Gamboa PM; Viñuela JE; Sanz ML; Andreu C; Martínez A
Clin Exp Allergy; 2009 Jul; 39(7):1088-98. PubMed ID: 19400901
[TBL] [Abstract][Full Text] [Related]
39. IgE modification of the specific antidermatophagoides during the first year of specific immunotherapy (SIT).
Vanacore R; Ferrara MP; Berni R; Luchetti A; Gianfaldoni ML; Sbrana S; Ambrogi F
Allerg Immunol (Paris); 1992 Dec; 24(10):387-9. PubMed ID: 1288544
[TBL] [Abstract][Full Text] [Related]
40. Effect of specific immunotherapy versus loratadine on serum adhesion molecules.
Ferreira MB; Santos MC; Pregal AL; Alonso E; Santos AS; Palma-Carlos ML; Palma-Carlos AG
Allerg Immunol (Paris); 2001 Oct; 33(8):319-22. PubMed ID: 11763722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]